Literature DB >> 6033811

Studies of the blood-brain barrier utilizing hematoporphyrin.

B L Wise, D R Taxdal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6033811     DOI: 10.1016/0006-8993(67)90171-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  6 in total

1.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

2.  Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.

Authors:  D P Boisvert; J D McKean; J Tulip; J Cummins; M K Cheng
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

3.  Photosensitization of human glioma cells by chalcogenapyrylium dyes.

Authors:  S K Powers; D L Walstad; J T Brown; M Detty; P J Watkins
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

4.  Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative.

Authors:  H Kostron; M R Swartz; R L Martuza
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

5.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

6.  Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action.

Authors:  M C Berenbaum; G W Hall; A D Hoyes
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.